Ropivacain Fresenius 2 mg/ml

Ropivacain Fresenius 2 mg/ml is a medicine authorised by Swissmedic under authorisation number 61877. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 April 2011 and the authorisation is valid without a time limit. ATC code N01BB09 places the medicine in the group Anesthetics.

  • Dispensing category B
  • Authorisation number 61877
  • ATC N01BB09
  • Synthetic medicines
Authorisation data
Authorisation number61877
NameRopivacain Fresenius 2 mg/ml
Full nameRopivacain Fresenius 2 mg/ml, Injektions-/Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN01BB09
First authorisation07 April 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ropivacain Fresenius 2 mg/ml, Injektions-/InfusionslösungB07 April 2011
2Ropivacain Fresenius 5 mg/ml, InjektionslösungB07 April 2011
3Ropivacain Fresenius 7.5 mg/ml, InjektionslösungB07 April 2011
4Ropivacain Fresenius 10 mg/ml, InjektionslösungB07 April 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
25 x 100mlN01BB0901.02.2.B
55 x 200mlN01BB0901.02.2.B
85 x 10mlN01BB0901.02.2.B
115 x 20mlN01BB0901.02.2.B
145 x 10mlN01BB0901.02.2.B
175 x 10mlN01BB0901.02.2.B
205 x 20mlN01BB0901.02.2.B
235 x 10mlN01BB0901.02.2.B
265 x 20mlN01BB0901.02.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ropivacain Fresenius 2 mg/ml authorised in Switzerland?

Yes. Ropivacain Fresenius 2 mg/ml is authorised by Swissmedic under authorisation number 61877, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ropivacain Fresenius 2 mg/ml have?

Ropivacain Fresenius 2 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ropivacain Fresenius 2 mg/ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com